DPT Laboratories, a contract development and manufacturing organization (CDMO) with a specialized focus on semi-solid and liquid dosage forms, has announced the acquisition of Meda Pharmaceuticals’ Lakewood, New Jersey, facilities.
The acquisition reflects the organization’s recent growth, allowing DPT to expand its footprint in Lakewood by adding two buildings totaling 90,000 square feet of space. The real estate meets the organization’s current need for additional cold storage and a larger state-of-the-art analytical laboratory.
“The Meda Pharmaceuticals space allows us to meet the needs of our clients today and beyond,” said Gene Ciolfi, vice president and general manager, Lakewood site operations.
“We are also in a better position to explore additional opportunities to further our capabilities from development through commercialization.”
As part of the acquisition, DPT will also absorb Meda Pharmaceuticals’ employees to continue the manufacturing of MUSE®, its urethral suppository product.
“We look forward to transitioning Meda Pharmaceuticals’ personnel to the DPT team,” Ciolfi commented. “Their experience and continued dedication to quality complements our commitment to outstanding client service.”
DPT’s current Lakewood location is one of the organization’s established Centers of Excellence. This center provides state-of-the-art aseptic processing suites and filling equipment for small-volume parenterals, ophthalmic preparations, preservative-free nasal sprays and sterile ointments
